Skip to content

Gain Therapeutics Inc

GANX

Latest QuantConomy context for GANX: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class
stock
Primary venue
NASDAQ
Recent signals
3
SEC filings
2
Asset profile

Gain Therapeutics Inc

QuantConomy has a structured record for GANX. More descriptive asset metadata will appear here when the platform record includes it.

Symbol
GANX
Name
Gain Therapeutics Inc
Coverage
3 market/data records
Sources
alpaca fmp alphavantage sec nasdaq
Latest signal rows

Recent signals for GANX

Scored rows are pulled from the same signal API used by the digests.

Signal Direction Score Observed Reason
volume spike
neutral
42
Jul 10, 05:23 PM GANX volume spike: 415% of expected volume for Friday 17:00 UTC, price flat 0.00% (strength 42)
uptrend
slightly bullish
28
Jul 10, 05:07 PM GANX uptrend (gain): price 1.42% (strength 28, current 1.79)
volume spike
neutral
38
Jul 10, 03:45 PM GANX volume spike: 296% of expected volume for Friday 15:00 UTC, price flat 0.00% (strength 38)

EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).

PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.

Market coverage

Market Exchange Source Asset record
GANX NASDAQ alpaca Gain Therapeutics, Inc. Common Stock
GANX NASDAQ fmp Gain Therapeutics, Inc.
GANX NASDAQ alphavantage Gain Therapeutics Inc

Recent insider transactions

Buys, last 90d
0
Sells, last 90d
0
Rows
2
Date Insider Role Type Shares Price Value Filing
Mar 24, 2026 Mack Gene CEO, President grant 200,000 4 on EDGAR
Mar 24, 2026 Fuggetta Gianluca See Remark grant 50,000 4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

Query GANX context like a database.

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.

No spam, no noise. Just the launch and the occasional preview.

More: All insider trades · How to read a Form 4 · API access